Scale -

  • Revenue is 28.3 Rs Cr; Continuous Decline over 3 years; 5 Year CAGR is -22 %
  • Ebitda is -5.75 Rs Cr; in Bottom Quartile
  • PAT is -23.29 Rs Cr; in Bottom Quartile

Profitability -

  • PBDIT Margin is -20.33 %; in Bottom Quartile
  • PAT Margin is -82.31 %; in Bottom Quartile

Return -

  • Asset Turnover is 26 %; Annual Growth is 37 %; in Bottom Quartile
  • ROA is -37.84 %; Annual Decline is -127 %; Continuous Decline over 3 years; in Bottom Quartile
  • ROE is -272.87 %; Annual Decline is -240 %; Continuous Decline over 3 years; in Bottom Quartile
  • ROCE is -29.83 %; Continuous Decline over 3 years; in Bottom Quartile

Efficiency -

  • Quick Ratio is 0.61; Annual Growth is 56 %; in Bottom Quartile
  • Inventory Turnover Ratio is 1.82; Annual Growth is 98 %; in Bottom Quartile
  • Operating cash flow is 20.51 Rs Cr; in Top Quartile; 5 Year CAGR is 24 %
  • Current Ratio is 0.78; in Bottom Quartile

Solvancy -

  • Total Debt is 28.66 Rs Cr; Annual Decline is -48 %; Continuous Decline over 3 years
  • Debt/Equity is 3.36; Annual Growth is 98 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 31 %
  • Long term Debt is 20.16 Rs Cr; Annual Growth is 194 %; in Top Quartile
  • Contingent Liabilities is 0 Rs Cr; in Top Quartile

Quality -

  • Change in Inventories/Total Expenses is 14 %; Annual Decline is -32 %; in Top Quartile
  • Current Tax/PAT is 0 %; Continuous Decline over 3 years; in Bottom Quartile
  • Other Expenses/Total Expenses is 17 %; Annual Growth is 73 %; Continuous Growth over 3 years
  • Operating cashflow/ebitda is -357 %; Continuous Decline over 3 years; in Bottom Quartile
  • Operating cashflow/PAT is -88 %; Continuous Decline over 3 years
  • Exceptional Items/PBT is 57 %; Continuous Growth over 3 years; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector
Major Subsidiaries/Associates
Key Clients

Products

Products
Product details

Operations

Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Cian Healthcare Limited Estimates – BSE:CHCL
Read More
  • Past/current
Top 14 Pharma Stocks To Buy In India October 2026
Read More
  • Past/current
Cian Healthcare ???? ??????? ??????? ???? ?????; NCLT ???? ??????????? Dr. Smiths Biotech ?????
Read More
  • Past/current
Cian Healthcare Subsidiary Dr. Smiths Biotech Ceases After NCLT Resolution Plan
Read More
  • Past/current
Cian Healthcare: ?????????? NCLT ???????.. ?? Dr. Smiths Biotech ?? ?????? ????!
Read More
  • Past/current
Cian Healthcare: NCLT ?? ???? ??? ????? ????? Dr. Smiths Biotech ?? ???? ??????
Read More
  • Past/current
Cian Healthcare: NCLT ?? ????? ?? ??? ???? ???? ?????????? ?? ???? ????
Read More
  • Past/current